Analyst Price Target is $2.46
▲ +40.08% Upside Potential
This price target is based on 11 analysts offering 12 month price targets for Beauty Health in the last 3 months. The average price target is $2.46, with a high forecast of $5.00 and a low forecast of $1.00. The average price target represents a 40.08% upside from the last price of $1.76.
Current Consensus is
Reduce
The current consensus among 11 polled investment analysts is to reduce stock in Beauty Health. This Reduce consensus rating has held steady for over two years.
The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.
Read More